Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.
Stocks
PFRM3
BRPFRMACNOR1
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.590 BRL | +3.94% |
|
+0.76% | -27.82% |
Company Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 747.9 | 723.4 | 450 | 747.9 | 795.7 | 1,119 |
| Change | - | -3.28% | -37.8% | 66.21% | 6.39% | 40.68% |
| Enterprise Value (EV) 1 | 1,277 | 1,482 | 1,291 | 1,698 | 1,813 | 2,286 |
| Change | - | 16.05% | -12.88% | 31.53% | 6.77% | 26.1% |
| P/E | 14.3x | 9.25x | 5.56x | 10.6x | 6.95x | 9.42x |
| PBR | 0.71x | 0.67x | 0.38x | 0.6x | 0.61x | 0.83x |
| PEG | - | 0.2x | 1.62x | -0.8x | 0.1x | 2.46x |
| Capitalization / Revenue | 0.14x | 0.11x | 0.06x | 0.09x | 0.08x | 0.1x |
| EV / Revenue | 0.23x | 0.23x | 0.17x | 0.2x | 0.18x | 0.2x |
| EV / EBITDA | 8.52x | 9.11x | 4.54x | 5.74x | 5.3x | 5.65x |
| EV / EBIT | 9.95x | 10.9x | 5.09x | 6.5x | 6.05x | 6.53x |
| EV / FCF | -50.4x | -136x | -22.6x | -101x | 11.3x | 34.7x |
| FCF Yield | -1.98% | -0.73% | -4.42% | -0.99% | 8.82% | 2.88% |
| Dividend per Share 2 | - | 0.2706 | 0.1733 | 0.3858 | 0.575 | - |
| Rate of return | - | 4.59% | 4.72% | 6.32% | 8.86% | - |
| EPS 2 | 0.4268 | 0.6377 | 0.6596 | 0.574 | 0.934 | 0.9697 |
| Distribution rate | - | 42.4% | 26.3% | 67.2% | 61.6% | - |
| Net sales 1 | 5,481 | 6,413 | 7,816 | 8,662 | 10,154 | 11,451 |
| EBITDA 1 | 149.9 | 162.7 | 284.2 | 295.6 | 342.1 | 404.5 |
| EBIT 1 | 128.3 | 136.3 | 253.8 | 261.1 | 299.7 | 350.1 |
| Net income 1 | 52.33 | 78.19 | 80.87 | 70.4 | 114.6 | 118.9 |
| Net Debt 1 | 528.9 | 758.4 | 840.9 | 950 | 1,017 | 1,167 |
| Reference price 2 | 6.100 | 5.900 | 3.670 | 6.100 | 6.490 | 9.130 |
| Nbr of stocks (in thousands) | 122,611 | 122,611 | 122,611 | 122,611 | 122,611 | 122,611 |
| Announcement Date | 16/3/21 | 16/3/22 | 15/3/23 | 7/3/24 | 18/3/25 | 17/3/26 |
1BRL in Million2BRL
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 156M | ||
| 18.06x | 0.22x | 12.53x | 0.44% | 89.39B | ||
| 30.64x | 0.24x | 15.31x | 0.87% | 55.72B | ||
| 43.42x | 3.07x | 28.48x | 1.43% | 22B | ||
| 10.61x | 0.19x | 4.57x | 2.83% | 7.63B | ||
| 11.76x | 0.89x | 7.2x | 2.87% | 6.81B | ||
| 5.51x | 0.09x | 2.58x | 5.45% | 6.28B | ||
| 9.32x | 1.74x | 5.55x | 3.51% | 6.18B | ||
| 24.37x | 1.17x | 14.47x | 2.96% | 5.28B | ||
| 9.89x | 0.11x | 4.02x | 4.52% | 3.39B | ||
| Average | 18.18x | 0.86x | 10.52x | 2.76% | 20.28B | |
| Weighted average by Cap. | 23.15x | 0.62x | 13.93x | 1.22% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PFRM3 Stock
- Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.
Select your edition
All financial news and data tailored to specific country editions
















